Bio-Techne Corp. buy UBS Group AG
Start price
05.02.26
/
50%
€56.00
Target price
05.02.27
-
Performance (%)
-9.68%
Price
18.02.26
€50.50
Summary
This prediction is currently active. With a performance of -9.68%, the BUY prediction for Bio-Techne Corp. by UBS_Group_AG is down slightly. Dividends of €0.080 are taken into consideration when calculating the performance. This prediction currently runs until 05.02.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Bio-Techne Corp. | -7.339% |
| iShares Core DAX® | 1,43 % |
| iShares Nasdaq 100 | 1,89 % |
| iShares Nikkei 225® | -1,62 % |
| iShares S&P 500 | 1,92 % |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for TECH provided by MarketBeat